Cancer Supportive Care

Cancer Supportive Care has emerged as a significant growth area for the biotechnology and pharmaceutical industry. With the dramatic improvement in the survivorship of cancer patients, focus is rapidly shifting to the development of new drugs and therapeutics that address the complications of cancer treatment.

Biomodels is the world leader in Cancer Supportive Care research through its expertise in developing innovative models based on a thorough understanding of the toxicities associated with chemotherapy and radiotherapy in the treatment of carcinomas.  While Biomodels is internationally recognized for its groundbreaking work in oral mucositis, we have also developed innovative models for proctitis, osteonecrosis, fatigue, dermatitis, hemostasis, myelosuppression, and neurological toxicity.

Subscribe to RSS - Cancer Supportive Care